Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
qimei granule
- Development stage
- Unknown
- Lead developer
- Shanghai Changhai Hospital
- Administration
- Oral
01
Overview
Qimei granule is a Traditional Chinese Medicine (TCM) hospital preparation developed by Shanghai Changhai Hospital for the treatment of chronic pancreatitis. The formulation is based on the TCM principle of treating "Jue Yin" patterns, which are associated with the complex symptoms of chronic pancreatitis, including persistent abdominal pain and pancreatic dysfunction. It is currently being evaluated in clinical trials, such as a Phase 1 randomized, double-blind, placebo-controlled study (ChiCTR2300072506), to assess its safety and therapeutic efficacy in managing pain and improving the quality of life for patients with chronic pancreatitis.
- Other names
- 齐美颗粒Qimei KeliQi-Mei granule
Beyond the preview
Go deeper on qimei granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on qimei granule.